National Meeting Highlights PAINWeek 2014
Release Date: October 08, 2014
Expiration Date: October 08, 2015
Expected time to complete this activity as designed: 60 minutes
There are no fees for participating in or receiving credit for this online activity.
This educational activity offers highlights from key sessions presented at PainWeek 2014. Key thought leaders summarize the latest information in pain management today. This four module highlight series focuses on the latest data, on what the data means in the clinical setting, and how clinicians may effectively incorporate this information to improve patient care, and ultimately, patient outcomes.
This activity is designed for pain management specialists, as well as primary care specialists, nurses, nurse practitioners, and pharmacists who provide care to patients with chronic pain.
Upon completion of this educational activity, participants should be able to:
- Summarize recent data regarding safety and efficacy of current and novel approaches to management of chronic pain
- Apply the clinical relevance and potential impact of these findings in the care of patients with chronic pain
- Identify key recommendations from clinical practice guidelines and standardized approaches to therapy with opioids that minimize risk and are designed to optimize outcomes
ICD-10 for Pain Management – Marvel J. Hammer, RN, BS, CPC, CCS-P, ACS-PM, CPCO
Pain Therapeutics − Chris Herndon, PharmD, BCPS, CPE, FASHP
The Psychology of Opioids − Mark D. Sullivan, MD
Learning to Identify Behavioral Profiles Common in Patients Struggling with Chronic Pain – Anthony Whitney, MS, LMHC, BCIA
Instructions for Participation and Credit
This activity is eligible for credit through October 8, 2015. After this date, this activity will expire and no further credit will be awarded.
- Read the target audience, learning objectives, and faculty disclosures.
- You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
- Complete the educational content as designed.
- Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
- Complete the activity evaluation survey to provide feedback and information useful for future programming.
- Certificates may be printed immediately after successfully completing the post-test and activity evaluation.
Marvel J. Hammer, RN, BS, CPC, CCS-P, ACS-PM, CPCO
Marvel Hammer is an accomplished professional with considerable years of experience both in the business and medical fields. She is a coding, billing and compliance consultant and owner of MJH Consulting based in Denver, Colorado.
Ms. Hammer provides medical coding and billing education, assistance with payer audits, and performs compliance reviews for her clients. She enjoys teaching providers and their staff on correct coding and billing issues and presents on these topics nationwide. Her field of specialties includes ICD-10-CM, pain management, physical medicine and rehabilitation, neurology, and occupational medicine.
Chris Herndon, PharmD, BCPS, CPE, FASHP
Southern Illinois University Edwardsville School of Pharmacy
Clinical Associate Professor
St. Louis University School of Medicine
St. Louis, Missouri
Dr. Chris Herndon received his doctor of pharmacy degree from the St. Louis College of Pharmacy. He then completed a geriatric pharmacotherapy specialty residency at the University of New Mexico Health Sciences Center. He is currently an associate professor with the Southern Illinois University Edwardsville (SIUE) School of Pharmacy and a clinical associate professor with the St. Louis University School of Medicine.
Currently, Dr. Herndon sees chronic pain patients in a multidisciplinary setting within a large family medicine residency clinic. His scholarship interest focuses primarily on pain and palliative care education and he is the co-principal investigator for the NIH Center of Excellence in Pain Education at SIUE and St. Louis University. Dr. Herndon is active in professional service and serves on the Board of Directors for the Midwest Pain Society, the Clinical Practice Guidelines Committee for the American Pain Society, the Section Advisory Group on Pain and Palliative Care for the American Society of Health-System Pharmacists, and the Curriculum Task Force, Pharmacy for the International Association for the Study of Pain. He is the 2012 recipient of the “Academic Pain Educator of the Year Award” from the American Society of Pain Educators.
Mark D. Sullivan, MD
Professor of Psychiatry
Adjunct Professor, Bioethics and Humanities
University of Washington
UW Medicine, School of Medicine
Dr. Mark Sullivan is a professor of psychiatry and adjunct professor of bioethics and humanities at University of Washington, UW Medicine, School of Medicine. He provides psychiatric consultation services in the UW Medicine Center for Pain Relief with a focus on diagnosing and treating depression and anxiety in patients with chronic pain. Previously, Dr. Sullivan served as attending physician in the UWMC Multidisciplinary Pain Center and also worked in the UW General Internal Medicine Center where he developed nationally disseminated training programs and policies concerning opioid management of chronic pain.
Dr. Sullivan serves on the Industrial Insurance Medical Advisory Committee of Washington state and has been involved with the development and evaluation of the Washington state opioid dosing guideline. He has been chair of the ethics committee of the American Pain Society and on the editorial board of Pain. He has published more than 150 peer-reviewed articles, many on chronic pain. He is currently participating in National Institute on Drug Abuse-funded studies on trends and risks of opioid therapy for chronic pain.
Anthony A. Whitney, MS, LMHC, BCIA
St. Luke’s Rehabilitation Institute
Anthony Whitney earned his bachelor degree in psychology and his master degree in clinical psychology at Eastern Washington University in Seattle, and is a certified biofeedback therapist and licensed mental health counselor. He is currently a behavioral therapist at St. Luke’s Rehabilitation Institute, Spokane, Washington, and specializes in treating chronic pain and biofeedback therapy. Mr. Whitney strives to create a unique treatment experience to enhance individuals’ abilities to experience their full internal potential. His philosophy integrates psychology with technology to improve a patient’s physical awareness and ability to work toward recovery.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-14-026-H01-P. Knowledge-based CPE activity.
In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 14-026-353
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.
Marvel Hammer has received honoraria as a consultant from Alere Toxicology, AllMeds, Boston Scientific Corporation, Clint Pharmaceuticals, and Wolters Kluwer Health.
Dr. Chris Herndon and Anthony Whitney have disclosed no relevant financial relationships.
Dr. Mark Sullivan has received honoraria related to the development of educational materials from the REMS Program Committee.
Planning Committee Disclosure
The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, has no relevant financial relationships.
Peer Reviewer Disclosure
In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Ms. Hammer, Dr. Herndon, Dr. Sullivan, and Mr. Whitney have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.
Ms. Hammer, Dr. Herndon, Dr. Sullivan, and Mr. Whitney have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.
MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at firstname.lastname@example.org.
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Purdue Pharma, L.P.
©2014 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.